Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Cecchini
Yale University Cancer Center LAO
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
32 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- City of Hope Corona
Corona, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- City of Hope Antelope Valley
Lancaster, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Ucsf Medical Center-Mount Zion
San Francisco, California, United States
- City of Hope South Pasadena
South Pasadena, California, United States
- City of Hope Upland
Upland, California, United States
- Smilow Cancer Hospital-Derby Care Center
Derby, Connecticut, United States
- Smilow Cancer Hospital Care Center-Fairfield
Fairfield, Connecticut, United States
- Smilow Cancer Hospital Care Center - Guilford
Guilford, Connecticut, United States
- Smilow Cancer Hospital Care Center at Saint Francis
Hartford, Connecticut, United States
- Smilow Cancer Center/yale-New Haven Hospital
New Haven, Connecticut, United States
- Yale University
New Haven, Connecticut, United States
- Yale-New Haven Hospital North Haven Medical Center
North Haven, Connecticut, United States
- Smilow Cancer Hospital-Orange Care Center
Orange, Connecticut, United States
- Smilow Cancer Hospital-Torrington Care Center
Torrington, Connecticut, United States
- Smilow Cancer Hospital Care Center-Trumbull
Trumbull, Connecticut, United States
- Smilow Cancer Hospital-Waterbury Care Center
Waterbury, Connecticut, United States
- Smilow Cancer Hospital Care Center - Waterford
Waterford, Connecticut, United States
- University of Florida Health Science Center - Gainesville
Gainesville, Florida, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Wayne State University/karmanos Cancer Institute
Detroit, Michigan, United States
- Weisberg Cancer Treatment Center
Farmington Hills, Michigan, United States
- Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
- Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital
New Brunswick, New Jersey, United States
- University of Pittsburgh Cancer Institute (upci)
Pittsburgh, Pennsylvania, United States
- Vanderbilt Breast Center at One Hundred Oaks
Nashville, Tennessee, United States
- Vanderbilt University/ingram Cancer Center
Nashville, Tennessee, United States
- M D Anderson Cancer Center
Houston, Texas, United States
- University of Wisconsin Carbone Cancer Center - University Hospital
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Feb 2018
- Primary completion
- 30 Jun 2023
- Completion
- 13 Aug 2025
- Last update posted
- 3 Feb 2026
- Registered enrollment
- 51
- Registry id
- NCT03008278
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.